Risk of Incident ESRD: A Comprehensive Look at Cardiovascular Risk Factors and 17 Years of Follow-up in the Atherosclerosis Risk in Communities (ARIC) Study

American Journal of Kidney Diseases

Volumn 55, Issue 1, 2010, Pages 31-41

  Bash, Lori D ^a,b   Astor, Brad C ^a,b,c   Coresh, Josef ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

End stage renal disease; estimated glomerular filtration rate; glomerular filtration rate; renal failure

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

AFRICAN AMERICANS; ATHEROSCLEROSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 71849091123     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.09.006     Document Type: Article

References (36)

1. US Renal Data System. USRDS 2006 Annual Data Report (2006), The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
2. US Renal Data System. USRDS 2008 Annual Data Report (2008), The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
3. Dubose Jr. T.D. American Society of Nephrology Presidential Address 2006: chronic kidney disease as a public health threat-new strategy for a growing problem. J Am Soc Nephrol 18 4 (2007) 1038-1045
4. Muntner P., Coresh J., Powe N.R., and Klag M.J. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol 14 6 (2003) 1568-1577
5. Roblin D.W., Khoury A., Pisanelli W., Dahar W., and Roth M. Risk for incident renal dialysis in a managed care population. Am J Kidney Dis 48 2 (2006) 205-211
6. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 1 (2003) 1-12
7. Collins A.J., Kasiske B., Herzog C., et al. Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis 45 1 suppl 1 (2005) A5-A7
8. Haroun M.K., Jaar B.G., Hoffman S.C., Comstock G.W., Klag M.J., and Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14 11 (2003) 2934-2941
9. Klag M.J., Whelton P.K., Randall B.L., et al. Blood pressure and end-stage renal disease in men. N Engl J Med 334 1 (1996) 13-18
10. Erlinger T.P., Tarver-Carr M.E., Powe N.R., et al. Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. Am J Kidney Dis 42 2 (2003) 256-263
11. Fried L., Solomon C., Shlipak M., et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 15 12 (2004) 3184-3191
12. Bash L.D., Erlinger T.P., Coresh J., Marsh-Manzi J., Folsom A.R., and Astor B.C. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 53 4 (2009) 596-605
13. Norris K.C., Greene T., Kopple J., et al. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol 17 10 (2006) 2928-2936
14. Ishani A., Grandits G.A., Grimm R.H., et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the Multiple Risk Factor Intervention Trial. J Am Soc Nephrol 17 5 (2006) 1444-1452
15. Iseki K., Iseki C., Ikemiya Y., Kinjo K., and Takishita S. Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan. Hypertens Res 30 2 (2007) 167-174
16. Muntner P., Coresh J., Klag M.J., Whelton P.K., and Perneger T.V. History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls: an analysis of shared risk factors. Am J Kidney Dis 40 2 (2002) 323-330
17. Hsu C.Y., McCulloch C.E., Darbinian J., Go A.S., and Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165 8 (2005) 923-928
18. Hall Y.N., Hsu C.Y., Iribarren C., Darbinian J., McCulloch C.E., and Go A.S. The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int 68 5 (2005) 2310-2316
19. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 1 (2006) 21-28
20. Iseki K., Ikemiya Y., Kinjo K., Inoue T., Iseki C., and Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65 5 (2004) 1870-1876
21. Hsu C.Y., Iribarren C., McCulloch C.E., Darbinian J., and Go A.S. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 169 4 (2009) 342-350
22. Iseki K., Ikemiya Y., Kinjo K., Iseki C., and Takishita S. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan. Clin Exp Nephrol 8 3 (2004) 250-256
23. Powe N.R., Tarver-Carr M.E., Eberhardt M.S., and Brancati F.L. Receipt of renal replacement therapy in the United States: a population-based study of sociodemographic disparities from the Second National Health and Nutrition Examination Survey (NHANES II). Am J Kidney Dis 42 2 (2003) 249-255
24. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 129 4 (1989) 687-702
25. Papp A.C., Hatzakis H., Bracey A., and Wu K.K. ARIC Hemostasis Study-I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 61 1 (1989) 15-19
26. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 6 (1972) 499-502
27. Stevens L.A., Coresh J., Feldman H.I., et al. Evaluation of the Modification of Diet in Renal Disease Study equation in a large diverse population. J Am Soc Nephrol 18 10 (2007) 2749-2757
28. Bash L.D., Selvin E., Steffes M., Coresh J., and Astor B.C. Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study. Arch Intern Med 168 22 (2008) 2440-2447
29. Brenner B.M., Levine S.A., and Rector F.C. Brenner & Rector's The Kidney. 7th ed. (2004), WB Saunders, Philadelphia, PA
30. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States (2005), US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
31. O'Hare A.M., Bertenthal D., Covinsky K.E., et al. Mortality risk stratification in chronic kidney disease: one size for all ages?. J Am Soc Nephrol 17 3 (2006) 846-853
32. Raymond N.T., Zehnder D., Smith S.C., Stinson J.A., Lehnert H., and Higgins R.M. Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age. Nephrol Dial Transplant 22 11 (2007) 3214-3220
33. Klag M.J., Whelton P.K., Randall B.L., Neaton J.D., Brancati F.L., and Stamler J. End-stage renal disease in African-American and white men. 16-Year MRFIT findings. JAMA 277 16 (1997) 1293-1298
34. Brancati F.L., Whelton P.K., Randall B.L., Neaton J.D., Stamler J., and Klag M.J. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 278 23 (1997) 2069-2074
35. Hsu C.Y., Go A.S., McCulloch C.E., Darbinian J., and Iribarren C. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease. Clin J Am Soc Nephrol 2 1 (2007) 81-88
36. Flegal K.M., Graubard B.I., Williamson D.F., and Gail M.H. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298 17 (2007) 2028-2037